(833) 317-6278
Book a Demo
Max Gelman
Gray shield icon
Is this you?
Claim your profile.

Max Gelman

Senior Editor

AS SEEN ON
Endpoints News, NewsBreak

Preston's Summary

Max Gelman is a Senior Editor for Endpoints News, a leading biotech and pharmaceutical news platform. With a focus on the healthcare industry, Max covers a wide range of topics including clinical trials, drug development, mergers and acquisitions, and regulatory updates. His articles provide insightful analysis and reporting on the latest developments in the biotech and pharmaceutical sectors.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

International

Coverage Attributes:

Beta
Press Release: 36 %
Cites Data: 24 %
Private Sector Announcements: 13 %
Investment Analysis: 4 %
Government Announcement: 4 %

Themes Covered:

Most Recent Topics:

  • Pharmaceuticals
  • FDA Approvals
  • Drug Development
  • Clinical Trials
  • Biotechnology

Pitching Insights

Max Gelman's articles predominantly cover the healthcare and pharmaceutical industry, with a focus on clinical trials, drug development, and medical research. His coverage heavily relies on cited data and press releases from private sector announcements.

Given Max's reliance on data-driven content, he is likely to be receptive to pitches that offer exclusive access to new findings or insights based on extensive data analysis within the healthcare and pharmaceutical sectors. Additionally, providing expert commentary or analysis of trends in biotech, pharmaceuticals, clinical trials or medical research might also capture his interest.

As Max does not have a specified geographic focus but seems to cover global developments in the industry; therefore sources with an international perspective may resonate well with him.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Max Bayer

Max Bayer

Staff Writer
*****m@*********om
Publications
Endpoints News, Biotech
Most recent topics
Healthcare & Pharmaceutical, Biotechnology, Business & Industry, Sales & Marketing, Scientific
Paul Schloesser

Paul Schloesser

Associate Editor
Publications
Endpoints News
Most recent topics
Healthcare & Pharmaceutical, Biotechnology, Scientific, Product Promotions, Sales & Marketing
Amber Tong

Amber Tong

Senior Editor
****r@**************com
Publications
Endpoints News
Most recent topics
Healthcare & Pharmaceutical, Biotechnology, Content & Publishing, Scientific, Sales & Marketing
Lei Lei Wu

Lei Lei Wu

News Reporter
**u@**************com
Publications
Endpoints News
Most recent topics
Healthcare & Pharmaceutical, Biotechnology, Scientific, Product Promotions, Content & Publishing
Ayisha Sharma

Ayisha Sharma

Biopharma Breaking News Reporter
******a@********om
Publications
Endpoints News, fitandwell.com
Most recent topics
Healthcare & Pharmaceutical, Data & Analytics, Biotechnology, Sales & Marketing, Scientific
Gene Tx

Gene Tx

Publications
Endpoints News
Most recent topics
Healthcare & Pharmaceutical, Biotechnology, Scientific, Manufacturing, Data & Analytics

Articles

© 2024 Intelligent Relations